Skip to content

H.E.L.P. System

by B.Braun Avitum AG

PMA P940016

Active European Union and United States

CE MDR PMA

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P940016↗

FDA record

Trust

Unverified

Source FDA PMA, synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP940016 Date19 Sep 1997ApprovedStatusActive
European UnionCE/MDR Number— Date—StatusActive

Official records

From the FDA record

FDA PMA P940016

Received by the FDA
1 Jun 1994
FDA decision
19 Sep 1997
FDA review time
1,206 days from receipt to decision
Docket number
98M-0138
Approval order statement, verbatim
Approval for the H.E.L.P. System. The device is a low density lipoprotein cholesterol (LDL-C) apheresis system, indicated for use in perofrming LDL-C apheresis to acutely remove LDL-C from the plasma of high risk patient populations for whom diet has been ineffective or not tolerated.

From the FDA PMA record P940016 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDR Active
  • United States FDA PMA Active

Specification

PMA

Full name
Heparin-Induced Extracorporeal Lipoprotein Precipitation (H.E.L.P.) System
Trade name
H.E.L.P. System
Generic name
Lipoprotein, low density, removal
FDA applicant
B. Braun Avitum AG
PMA number
FDA product code
MMY
Device class
Class III
Advisory committee
Gastroenterology, Urology
FDA decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The H.E.L.P. System is a low density lipoprotein cholesterol (LDL-C) apheresis system manufactured by B. Braun Avitum AG. It is designed to perform LDL-C apheresis to acutely remove low density lipoprotein cholesterol from the plasma of high-risk patient populations.

This device is indicated for patients for whom diet has been ineffective or not tolerated. The system has received FDA PMA authorization for its clinical application in managing cholesterol levels.

Devices cleared under P940016

2 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under P940016
UDI-DISize and differences
B.BRAUN 7210934
B.Braun Avitum AG
7210934 / 721093404046963847418 —On the market
H.E.L.P.® 7061192
B.Braun Avitum AG
7061192 / 706119204046964699467 —On the market

Other devices from B.Braun Avitum AG

See all devices from B.Braun Avitum AG →